Redburn Atlantic Adjusts Amgen Price Target to $180 From $170, Maintains Sell Rating
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Amgen Price Target Raised to $381.00/Share From $360.00 by TD Cowen
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Amgen Analyst Ratings
Piper Sandler Releases a Buy Rating on Amgen (AMGN)
Wells Fargo Downgrades Amgen to Equalweight From Overweight, Adjusts Price Target to $335 From $320
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Jefferies Adjusts Price Target on Amgen to $380 From $375
Amgen Analyst Ratings
Morgan Stanley Adjusts Price Target on Amgen to $303 From $310
Amgen Analyst Ratings
Amgen Analyst Ratings
Research Alert: CFRA Adds Amgen Inc. To The High-quality Capital Appreciation Portfolio
Barclays Sticks to Its Hold Rating for Amgen (AMGN)
HSBC Adjusts Price Target on Amgen to $356 From $322
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating